Ligand ID: FVX Drugbank ID: DB00176(Fluvoxamine) Indication:Indicated predominantly for the management of depression and for Obsessive Compulsive Disorder (OCD) [FDA Label]. Has also been used in the management of bulimia nervosa [A250]. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 9 | ASP A 153SER A 158SER B 123GLY B 124THR A 292 | 1.68A | 20.55 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 1uk3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 220ILE B 259ALA B 260THR B 224ALA B 267 | 1.26A | 21.46 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 1wnc | E2 GLYCOPROTEIN (SARSr-CoV) | 6 / 12 | LEU A 927ILE A1160ALA B 926THR B 923ALA C 926THR C 923 | 1.69A | 13.79 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 1xak | ORF7A ACCESSORYPROTEIN (SARSr-CoV) | 5 / 11 | ALA A 49TYR A 60PHE A 31SER A 29GLY A 27 | 1.63A | 10.00 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 1zv8 | E2 GLYCOPROTEIN (SARSr-CoV) | 6 / 12 | LEU C 27ILE B 12ALA E 26THR E 23ALA A 26THR A 23 | 1.63A | 7.46 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 12 | LEU C 235ILE C 217ALA C 271ALA C 238THR C 239 | 1.23A | 19.23 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2amq | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 220ILE A 259ALA A 260THR A 224ALA A 267 | 1.29A | 21.62 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2amq | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.61A | 20.73 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2beq | SPIKE GLYCOPROTEIN (SARSr-CoV) | 6 / 12 | LEU B 927ILE D1161ALA C 926THR C 923ALA A 926THR A 923 | 1.63A | 5.92 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2dd8 | IGG HEAVY CHAINIGG LIGHT CHAIN (Homosapiens) | 5 / 9 | SER L 178SER H 179SER H 180GLY H 139THR L 115 | 1.55A | 15.70 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 2dd8 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 11 | ALA S 406TYR S 410PHE S 416GLY S 400ASP S 385 | 1.22A | 18.51 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 12 | LEU A 54ILE A 36ALA A 90ALA A 57THR A 58 | 1.23A | 19.58 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 11 | ALA C 140TYR C 137GLY C 101SER C 104GLY C 143 | 1.58A | 22.39 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 2ghv | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 11 | ALA E 406TYR E 410PHE E 416GLY E 400ASP E 385 | 1.27A | 15.38 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2ghw | ANTI-SCFV ANTIBODY,80RSPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 9 | ASN C 479SER D 163PHE D 203SER D 184SER D 195 | 1.71A | 16.94 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 2gri | NSP3 (SARSr) | 5 / 11 | VAL A 62ALA A 61PHE A 88SER A 84ASP A 29 | 1.33A | 14.39 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2h85 | PUTATIVE ORF1ABPOLYPROTEIN (SARSr-CoV) | 6 / 12 | PHE A 329LEU A 297ILE A 295ILE A 305THR A 192ALA A 325 | 1.71A | 21.17 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2k87 | NSP3 OF REPLICASEPOLYPROTEIN 1A (SARSr) | 5 / 9 | ASP A 21SER A 47PHE A 42GLY A 41THR A 26 | 1.48A | 11.48 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 6 / 12 | PHE C 329LEU C 297ILE C 295ILE C 305THR C 321ALA C 325 | 1.43A | 21.73 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2pwx | 3C-LIKE PROTEINASE (SARS-COVBJ01) | 5 / 12 | ALA A 193THR A 196GLY A 138ALA A 173THR A 135 | 1.25A | 21.68 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | LEU A 220ILE A 259ALA A 260THR A 224ALA A 267 | 1.30A | 21.46 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2qc2 | 3C-LIKE PROTEINASE (-) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.62A | 20.84 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 6 / 12 | PHE B 302LEU B 331ILE B 306ALA B 234GLY B 246THR B 340 | 1.56A | 21.71 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 9 | ASP F 267ILE D 42SER F 273GLY D 13THR D 33 | 1.69A | 21.42 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.73A | 20.33 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 3aw0 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282ILE A 281ALA A 206GLY A 258ALA A 211 | 1.27A | 21.46 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 3bgf | SPIKE PROTEIN S1 (SARSr-CoV) | 5 / 11 | ALA S 406TYR S 410PHE S 416GLY S 400ASP S 385 | 1.22A | 14.88 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3bgf | F26G19 FAB (Musmusculus) | 5 / 9 | ASN C 161SER B 180SER B 181GLY B 141THR C 114 | 1.19A | 15.50 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3e91 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.60A | 20.70 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 3e9s | NSP3 (SARSr-CoV) | 5 / 11 | ALA A 140TYR A 137GLY A 101SER A 104GLY A 143 | 1.51A | 22.35 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 3ea7 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 220ILE A 259ALA A 260THR A 224ALA A 267 | 1.30A | 21.68 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 3f9e | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ALA A 193THR A 196GLY A 138ALA A 173THR A 135 | 1.27A | 21.88 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 3f9e | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 11 | VAL A 157GLY A 11SER A 113GLY A 149ASP A 155 | 1.44A | 20.67 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.73A | 20.36 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 11 | ASP A 216ALA B 140GLY A 283PHE A 3GLY A 2 | 1.62A | 20.87 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 3i6l | HLA, A-24 (Homosapiens) | 5 / 11 | ASP D 102VAL D 28GLY D 100GLY D 167ASP D 30 | 1.59A | 20.15 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.70A | 20.70 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 220ILE B 259ALA B 260THR B 224ALA B 267 | 1.18A | 21.68 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.55A | 20.84 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 3r24 | 2'-O-METHYLTRANSFERASENSP10 AND NSP11 (SARSr-CoV) | 5 / 12 | ALA A 107THR A 82ALA A 79GLY A 77ALA B 71 | 1.30A | 18.22 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3snd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP A 153SER A 158SER B 123GLY B 124THR A 292 | 1.64A | 20.70 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 11 | ALA A 140TYR A 137GLY A 101SER A 104GLY A 143 | 1.56A | 22.30 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 4mm3 | PAPAIN-LIKEPROTEINASE (SARSr-CoV) | 5 / 11 | ALA B 140TYR B 137GLY B 101SER B 104GLY B 143 | 1.51A | 22.35 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 4rna | PAPAIN-LIKE PROTEASE (Humanbetacoronavirus2cEMC/2012) | 6 / 12 | PHE A 79LEU A 133ILE A 130ALA A 150GLY A 12ALA A 132 | 1.80A | 22.42 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5b6o | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 220ILE A 259ALA A 260THR A 224ALA A 267 | 1.28A | 21.00 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 5c5o | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 111 | 1.64A | 20.88 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 11 | ALA D 140TYR D 137GLY D 101SER D 104GLY D 143 | 1.60A | 22.30 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 3PHE A 294LEU A 250ILE A 249ALA A 206 | 1.39A | 15.37 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 219LEU A 282ILE A 281ALA A 206ALA A 210 | 1.66A | 15.37 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 11 | ALA B 140TYR B 137GLY B 101SER B 104GLY B 143 | 1.42A | 22.22 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5wrg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | PHE B 741ILE B 724ILE B 975GLY A 981THR B 980 | 1.25A | 16.36 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5x4r | S PROTEIN (MERS-CoV) | 5 / 12 | ILE A 143ILE A 300ALA A 89ALA A 138GLY A 128 | 1.30A | 20.67 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5x4r | S PROTEIN (MERS-CoV) | 5 / 11 | VAL A 315TYR A 85GLY A 115GLY A 255ASP A 83 | 1.65A | 20.84 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5x4s | SPIKE GLYCOPROTEIN (SARSr-CoV) | 6 / 12 | PHE A 185ALA A 250ALA A 233TRP A 101GLY A 100ALA A 90 | 1.69A | 19.08 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 9 | ASP B 518PHE B 529SER B 310GLY B 311THR B 539 | 1.71A | 18.89 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5x59 | S PROTEIN (MERS-CoV) | 5 / 12 | ILE A 143ILE A 300ALA A 89ALA A 138GLY A 128 | 1.29A | 16.25 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 11 | VAL A 562GLY A 534PHE A 527GLY A 531ASP A 560 | 1.62A | 18.43 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5x5c | S PROTEIN (MERS-CoV) | 5 / 11 | VAL B 374ALA B 597GLY B 615PHE B 617GLY B 372 | 1.47A | 17.77 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5y3q | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 11 | ALA A 140TYR A 137GLY A 101SER A 104GLY A 143 | 1.50A | 22.41 | NoneNoneNone NA A 405 ( 3.9A)None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 5zvm | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | ILE B 955SER C 950PHE B 952SER B 957GLY B 953 | 1.50A | 9.98 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | PHE B 231LEU B 235ALA B 251THR B 92ALA B 90 | 1.23A | 16.36 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 11 | TYR B 660VAL B 642TYR B 677SER B 659ASP B 643 | 1.29A | 18.37 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | ASN A 155ILE A 226SER A 111SER A 105GLY A 104 | 1.44A | 19.01 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 11 | VAL C 642ALA C 676TYR C 677SER C 659ASP C 643 | 1.62A | 16.94 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | ILE C 226PHE C 130SER C 105GLY C 104THR C 160 | 1.76A | 18.72 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ALA B 695ALA C 866GLY C 862ALA C 874THR C 869 | 1.20A | 17.05 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | ASN C 692SER C 690PHE A 779GLY A 781THR A 775 | 1.40A | 18.72 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 11 | ASP B 191ALA A 406TYR A 410GLY A 400ASP A 385 | 1.35A | 17.42 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6crz | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | LEU B1045ILE B 800ALA B 926GLY B 928THR B 706 | 1.08A | 16.67 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6kl2 | NUCLEOPROTEIN (MERS-CoV) | 5 / 11 | VAL A 116ALA A 115GLY B 76PHE B 113ASP A 118 | 1.38A | 13.79 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 6 / 12 | LEU E 945ILE E1179ALA D 944THR D 941ALA F 944THR F 941 | 1.61A | 15.03 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | LEU A 282ILE A 281ALA A 206GLY A 258ALA A 211 | 1.38A | 21.91 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE A 219LEU A 282ILE A 281ALA A 206ALA A 210 | 1.65A | 21.91 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6lzg | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 9 | ASN B 388SER B 366PHE B 377SER B 514GLY B 431 | 1.75A | 17.15 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6m0j | SPIKE RECEPTORBINDING DOMAIN (SARS-CoV-2) | 5 / 11 | ALA E 419TYR E 423PHE E 429GLY E 413ASP E 398 | 1.24A | 17.41 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE A 219LEU A 282ILE A 281ALA A 206ALA A 210 | 1.64A | 21.87 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 9 | ASN A 54SER A 278PHE A 283SER A 431GLY A 434 | 1.00A | 32.53 | NoneNoneLEU A 707 (-3.8A)LEU A 707 (-4.2A)None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 11 | VAL C 125TYR C 128TYR C 129SER C 431ASP C 486 | 0.75A | 27.17 | NoneNoneLEU C 707 ( 3.9A)LEU C 707 (-4.2A)None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6m1d | ACE2 (Homosapiens) | 5 / 9 | ASP B 719ASN B 718ILE B 704SER B 721GLY B 726 | 1.12A | 20.99 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | LEU C 282ILE C 281ALA C 206GLY C 258ALA C 211 | 1.37A | 21.89 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE B 219LEU B 282ILE B 281ALA B 206ALA B 210 | 1.65A | 21.89 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE D 219LEU D 282ILE D 281ALA D 206ALA D 210 | 1.63A | 21.89 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE C 219LEU C 282ILE C 281ALA C 206ALA C 210 | 1.62A | 21.89 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE C 3PHE C 294LEU C 250ILE C 249ALA C 206 | 1.38A | 21.89 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE A 219LEU A 282ILE A 281ALA A 206ALA A 210 | 1.65A | 21.89 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m71 | NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 147LEU B 153ALA B 188ALA B 125ALA B 152 | 1.50A | 19.32 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | PHE A 504LEU B 98ILE B 120ALA A 400GLY A 671 | 1.54A | 19.77 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 165LEU A 127ILE A 145ALA A 176THR A 248 | 1.44A | 19.77 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | ILE B 119ALA B 150ALA B 125GLY A 385THR B 124 | 1.52A | 19.32 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 9 | ASP A 135ASN A 138ILE A 779SER A 784THR A 801 | 1.74A | 20.30 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 11 | VAL A 128GLY A 44PHE A 45SER A 236ASP A 126 | 1.64A | 19.01 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 891ILE A 888ALA A 863ALA A 840GLY A 839 | 1.55A | 19.77 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | ASN B 692SER B 690PHE A 779GLY A 781THR A 775 | 1.55A | 18.84 | NAG B1326 (-3.5A)NoneNoneNoneNone | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 11 | VAL B 642ALA B 676TYR B 677SER B 659ASP B 643 | 1.61A | 17.02 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6nb7 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU A1045ILE A 800ALA A 926GLY A 928THR A 706 | 1.09A | 16.18 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,LIGHT CHAIN (Homosapiens) | 5 / 9 | ILE L 21SER L 25SER L 70GLY L 69THR L 107 | 1.65A | 15.36 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6nur | NSP12NSP7 (SARSr-CoV) | 5 / 11 | VAL A 424ALA A 423TYR A 420GLY A 432ASP C 5 | 1.65A | 18.93 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6nur | NSP12NSP8 (SARSr-CoV) | 5 / 9 | ASP A 269ILE B 106SER A 325GLY B 113THR B 124 | 1.75A | 20.42 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 9 | ASN A 710ILE B 882SER A 708GLY B 885THR B 791 | 1.62A | 18.57 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | VAL B 576GLY B 548PHE B 541GLY B 545ASP B 574 | 1.49A | 19.61 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6vw1 | SARS-COV-2 CHIMERICRBD (SARSr) | 5 / 11 | ALA F 419TYR F 423PHE F 429GLY F 413ASP F 398 | 1.22A | 15.89 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6vw1 | SARS-COV-2 CHIMERICRBD (SARSr) | 5 / 11 | ALA E 419TYR E 423PHE E 429GLY E 413ASP E 398 | 1.27A | 15.89 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 9 | ASN B1098SER B1097PHE B1095GLY B1093THR B1116 | 1.73A | 18.80 | NAG B1317 (-1.9A)NoneNoneNoneNone | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 6 / 12 | LEU A 865ILE A 870ALA A 871ALA A 876GLY A 880ALA A 783 | 1.75A | 15.85 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | ALA A 419TYR A 423PHE A 429GLY A 413ASP A 398 | 1.30A | 19.14 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | ALA A 419TYR A 423PHE A 429GLY A 413ASP A 398 | 1.30A | 19.22 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 6 / 12 | LEU B 865ILE B 870ALA B 871ALA B 876GLY B 880ALA B 783 | 1.74A | 15.85 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6w37 | PROTEIN 7A (SARS-CoV-2) | 5 / 11 | ALA A 49TYR A 60PHE A 31SER A 29GLY A 27 | 1.62A | 6.98 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | PHE L 62ILE L 75ALA L 19GLY L 101ALA L 84 | 1.78A | 18.50 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 5 / 11 | TYR H 90GLY H 65SER H 60GLY H 49ASP H 86 | 1.57A | 15.78 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 9 | ASP H 54ILE H 98SER H 55GLY H 97THR L 94 | 1.65A | 15.09 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 9 | ILE H 98SER H 55SER H 96GLY H 95THR L 94 | 1.71A | 15.09 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 5 / 12 | PHE H 29ILE H 20ALA H 93GLY H 94ALA H 78 | 1.71A | 16.19 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 5 / 11 | ALA C 419TYR C 423PHE C 429GLY C 413ASP C 398 | 1.23A | 14.59 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 9 | ASP L 70SER L 25SER L 65GLY L 64THR L 102 | 1.72A | 14.29 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w4h | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA A6905THR A6880ALA A6877GLY A6875ALA B4324 | 1.31A | 19.96 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | PHE A6985LEU A6848ILE A7005ALA A7002ALA A6966 | 1.42A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | LEU A7078ILE A7080ALA A6960ALA A7056THR A7055 | 1.46A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA A6905THR A6880ALA A6877GLY A6875ALA B4324 | 1.30A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 11 | ALA A6881TYR A6845GLY A6875SER A6903ASP A6928 | 1.76A | NoneSAM A7104 (-4.6A)NoneNoneSAM A7104 (-3.8A) | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 219LEU A 282ILE A 281ALA A 206ALA A 210 | 1.64A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ALA B 89ALA B 56GLY B 51ALA B 60THR B 57 | 1.69A | 17.82 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ALA A 89ALA A 56GLY A 51ALA A 60THR A 57 | 1.70A | 17.82 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | PHE C6985LEU C6848ILE C7005ALA C7002ALA C6966 | 1.41A | 16.08 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA A6905THR A6880ALA A6877GLY A6875ALA B4324 | 1.30A | 16.08 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA C6905THR C6880ALA C6877GLY C6875ALA D4324 | 1.31A | 16.08 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | LEU A7078ILE A7080ALA A6960ALA A7056THR A7055 | 1.46A | 16.08 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | PHE A7003LEU A6887ALA A6881ALA A6870GLY A6869 | 1.80A | 16.08 | NoneNoneNoneNoneSAM A7102 ( 3.8A) | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | LEU C7078ILE C7080ALA C6960ALA C7056THR C7055 | 1.47A | 16.08 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | PHE A6985LEU A6848ILE A7005ALA A7002ALA A6966 | 1.41A | 16.08 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w75 | NSP10 (SARS-CoV-2) | 5 / 12 | LEU D4328ILE D4334ALA B4273ALA B4279ALA D4276 | 1.65A | 15.77 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 127LEU A 152ILE A 151ALA A 114THR A 168 | 1.61A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | PHE C 127LEU C 113ILE C 151ALA C 145ALA C 139 | 1.53A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 117ILE A 151ALA A 149THR A 90ALA A 139 | 1.45A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU B 117ILE B 151ALA B 149THR B 90ALA B 144 | 1.40A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 117ILE A 151ALA A 149THR A 90ALA A 144 | 1.40A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU C 113ILE C 151ALA C 153GLY C 38THR C 90 | 1.58A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU B 117ILE B 151ALA B 149THR B 90ALA B 139 | 1.47A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU B 132ALA B 149ALA B 144GLY B 142ALA B 135 | 1.50A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU C 117ILE C 151ALA C 149THR C 90ALA C 144 | 1.43A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 132ALA A 149ALA A 144GLY A 142ALA A 135 | 1.36A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU B 113ILE B 151ALA B 153GLY B 38THR B 90 | 1.62A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU C 117ILE C 151ALA C 149THR C 90ALA C 139 | 1.49A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | LEU C 291ILE C 304ALA D 313THR C 263THR C 296 | 1.43A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE F 315LEU E 353ILE F 320ILE E 304ALA E 305 | 1.48A | NoneNoneNoneNone CL E 401 ( 4.3A) | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE A 315LEU B 353ILE A 320ILE B 304ALA B 305 | 1.49A | NoneNoneNoneNone CL B 401 ( 4.3A) | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | LEU A 291ILE A 304ALA B 313THR A 263THR A 296 | 1.43A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE C 315LEU D 353ILE C 320ILE D 304ALA D 305 | 1.48A | NoneNoneNoneNone CL D 401 ( 4.6A) | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | LEU B 291ILE B 304ALA A 313THR B 263THR B 296 | 1.37A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE B 315LEU A 353ILE B 320ILE A 304ALA A 305 | 1.49A | NoneNoneNoneNone CL A 401 ( 4.3A) | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | LEU D 291ILE D 304ALA C 313THR D 263THR D 296 | 1.43A | NoneNoneNoneNone CL D 401 ( 4.6A) | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE D 315LEU C 353ILE D 320ILE C 304ALA C 305 | 1.48A | NoneNoneNoneNone CL C 401 ( 4.2A) | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | LEU F 291ILE F 304ALA E 313THR F 263THR F 296 | 1.40A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | LEU E 291ILE E 304ALA F 313THR E 263THR E 296 | 1.37A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE E 315LEU F 353ILE E 320ILE F 304ALA F 305 | 1.49A | NoneNoneNoneNone CL F 401 ( 4.0A) | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | PHE C6985LEU C6848ILE C7005ALA C7002ALA C6966 | 1.41A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | PHE A6985LEU A6848ILE A7005ALA A7002ALA A6966 | 1.42A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA C6905THR C6880ALA C6877GLY C6875ALA D4324 | 1.30A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | LEU A7078ILE A7080ALA A6960ALA A7056THR A7055 | 1.43A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | LEU C7078ILE C7080ALA C6960ALA C7056THR C7055 | 1.48A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA A6905THR A6880ALA A6877GLY A6875ALA B4324 | 1.33A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | LEU A7078ILE A7080ALA A6960ALA A7056THR A7055 | 1.46A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | PHE C6985LEU C6848ILE C7005ALA C7002ALA C6966 | 1.41A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | PHE A6985LEU A6848ILE A7005ALA A7002ALA A6966 | 1.42A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | LEU C7078ILE C7080ALA C6960ALA C7056THR C7055 | 1.47A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA C6905THR C6880ALA C6877GLY C6875ALA D4324 | 1.32A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ALA A6905THR A6880ALA A6877GLY A6875ALA B4324 | 1.33A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE A 330LEU A 298ILE A 296THR A 326THR A 275 | 1.50A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE B 233PHE B 330ILE B 306ILE B 323GLY B 254 | 1.33A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE A 330LEU A 298ILE A 296ILE A 306THR A 193 | 1.41A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE A 303LEU A 332ILE A 307GLY A 247THR A 341 | 1.53A | NoneNoneNoneNoneU5P A 401 ( 4.7A) | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE B 330LEU B 298ILE B 296THR B 326THR B 275 | 1.47A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE A 233PHE A 330ILE A 306ILE A 328GLY A 254 | 1.63A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE B 233PHE B 330ILE B 306ILE B 328GLY B 254 | 1.61A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE B 330LEU B 298ILE B 296ILE B 306THR B 193 | 1.41A | NoneNoneNoneNoneEDO B 404 (-4.8A) | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE B 303LEU B 332ILE B 307GLY B 247THR B 341 | 1.53A | NoneNoneNoneNoneU5P B 401 ( 4.8A) | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 11 | ALA B 60GLY B 21PHE B 8SER B 2ASP B 17 | 1.79A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 11 | ALA A 60GLY A 21PHE A 8SER A 2ASP A 17 | 1.78A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE A 233PHE A 330ILE A 306ILE A 323GLY A 254 | 1.35A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 219LEU A 282ILE A 281ALA A 206ALA A 210 | 1.65A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ALA A6905THR A6880ALA A6877GLY A6875ALA B4324 | 1.31A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | LEU A7078ILE A7080ALA A6960ALA A7056THR A7055 | 1.49A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | PHE A6985LEU A6848ILE A7005ALA A7002ALA A6966 | 1.43A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 3PHE A 294LEU A 250ILE A 249ALA A 206 | 1.36A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 219LEU A 282ILE A 281ALA A 206ALA A 210 | 1.66A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | LEU A 117ILE A 151ALA A 149THR A 90ALA A 139 | 1.44A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | LEU A 117ILE A 151ALA A 149THR A 90ALA A 144 | 1.54A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | LEU A 132ALA A 149ALA A 144GLY A 142ALA A 135 | 1.56A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | PHE A 304ALA A 261THR A 301ALA A 246GLY A 209 | 1.54A | NoneNoneGOL A 508 (-3.8A)NoneNone | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 11 | ALA A 139TYR A 136GLY A 100SER A 103GLY A 142 | 1.55A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | PHE A 127LEU A 113ILE A 151ALA A 145ALA A 139 | 1.61A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 9 | ASP A 153SER A 158SER B 123GLY B 124THR A 292 | 1.73A | 20.58 | NoneNoneGLY A 401 ( 4.7A)NoneNone | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE A 219LEU A 282ILE A 281ALA A 206ALA A 210 | 1.66A | 15.60 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE A 3PHE A 294LEU A 250ILE A 249ALA A 206 | 1.37A | 15.60 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ILE B 102SER B 56SER B 100GLY B 99THR C 100 | 1.57A | 15.81 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ILE H 102SER H 56SER H 100GLY H 99THR L 100 | 1.53A | 15.81 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | ALA A 419TYR A 423PHE A 429GLY A 413ASP A 398 | 1.28A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 9 | ILE C 21SER C 25SER C 71GLY C 70THR C 108 | 1.72A | 16.54 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | LEU C 52THR C 59ALA C 57GLY C 72ALA C 40 | 1.54A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | LIGHT CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 9 | ASN A 388ILE C 34PHE A 515SER A 383GLY A 381 | 1.74A | 16.70 | NoneNoneNoneDMS A 905 (-3.9A)None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | LEU L 52THR L 59ALA L 57GLY L 72ALA L 40 | 1.63A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | ALA E 419TYR E 423PHE E 429GLY E 413ASP E 398 | 1.28A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ASP B 55ILE B 102SER B 56GLY B 101THR C 100 | 1.52A | 15.81 | MLI B 302 ( 4.1A)NoneNoneNoneNone | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yla | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 11 | VAL E 407TYR E 508GLY H 54SER E 375ASP E 405 | 1.56A | NoneDMS E 902 (-4.0A)NoneNoneNone | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 11 | TYR H 94GLY H 66SER H 61GLY H 49ASP H 90 | 1.53A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ASP H 55ILE H 102SER H 56GLY H 101THR L 100 | 1.52A | 15.81 | MLI E 908 (-3.9A)NoneNoneNoneNone | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ILE H 102SER H 56SER H 100GLY H 98THR L 100 | 1.78A | 15.81 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 11 | TYR B 94GLY B 66SER B 61GLY B 49ASP B 90 | 1.54A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6ym0 | HEAVY CHAIN (Homosapiens) | 5 / 11 | TYR H 94GLY H 66SER H 61GLY H 49ASP H 90 | 1.55A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6ym0 | LIGHT CHAIN (Homosapiens) | 5 / 12 | LEU L 52THR L 59ALA L 57GLY L 72ALA L 40 | 1.55A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6ym0 | HEAVY CHAIN (Homosapiens) | 5 / 12 | PHE H 29ILE H 20ALA H 97GLY H 98ALA H 79 | 1.66A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ILE H 102SER H 56SER H 100GLY H 99THR L 100 | 1.60A | 15.94 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | ALA E 419TYR E 423PHE E 429GLY E 413ASP E 398 | 1.26A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6ym0 | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 11 | VAL E 407TYR E 508GLY H 54SER E 375ASP E 405 | 1.58A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ASP H 55ILE H 102SER H 56GLY H 101THR L 100 | 1.56A | 15.94 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE A 219LEU A 282ILE A 281ALA A 206ALA A 210 | 1.66A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | LEU L 52THR L 59ALA L 57GLY L 72ALA L 40 | 1.62A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ILE B 102SER B 56SER B 100GLY B 98THR C 100 | 1.77A | 15.81 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ILE H 102SER H 56SER H 100GLY H 99THR L 100 | 1.54A | 15.81 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 11 | TYR B 94GLY B 66SER B 61GLY B 49ASP B 90 | 1.53A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 11 | VAL E 407TYR E 508GLY H 54SER E 375ASP E 405 | 1.55A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ASP H 55ILE H 102SER H 56GLY H 101THR L 100 | 1.52A | 15.81 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | ALA A 419TYR A 423PHE A 429GLY A 413ASP A 398 | 1.28A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ILE H 102SER H 56SER H 100GLY H 98THR L 100 | 1.78A | 15.81 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 11 | TYR H 94GLY H 66SER H 61GLY H 49ASP H 90 | 1.52A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 11 | VAL A 407TYR A 508GLY B 54SER A 375ASP A 405 | 1.55A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ASP B 55ILE B 102SER B 56GLY B 101THR C 100 | 1.52A | 15.81 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | ALA E 419TYR E 423PHE E 429GLY E 413ASP E 398 | 1.27A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | LEU C 52THR C 59ALA C 57GLY C 72ALA C 40 | 1.62A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ILE B 102SER B 56SER B 100GLY B 99THR C 100 | 1.53A | 15.81 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | PHE A 219LEU A 282ILE A 281ALA A 206ALA A 210 | 1.64A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | PHE A 3PHE A 294LEU A 250ILE A 249ALA A 206 | 1.34A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 891ILE A 888ALA A 863ALA A 840GLY A 839 | 1.55A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7btf | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 270ALA B 150ALA B 125GLY A 385THR B 123 | 1.54A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 7btf | NSP12 (SARS-CoV-2) | 5 / 11 | ASP A 717VAL A 776ALA A 771TYR A 770GLY A 774 | 1.64A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 7btf | NSP12 (SARS-CoV-2) | 5 / 11 | TYR A 887ASP A 418VAL A 844GLY A 841ASP A 846 | 1.65A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 7btf | NSP12 (SARS-CoV-2) | 5 / 11 | VAL A 128GLY A 44PHE A 45SER A 236ASP A 126 | 1.68A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7btf | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | ILE B 119ALA B 150ALA B 125GLY A 385THR B 124 | 1.52A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7btf | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | PHE A 396LEU A 270ALA B 125GLY A 385THR B 123 | 1.60A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 165LEU A 127ILE A 145ALA A 176THR A 248 | 1.44A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | PHE A 219LEU A 282ILE A 281ALA A 206ALA A 210 | 1.64A | NoneDMS A 404 (-4.9A)NoneNoneNone | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 891ILE A 888ALA A 863ALA A 840GLY A 839 | 1.49A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | ASP C 5VAL A 424ALA A 423TYR A 420SER C 4 | 1.64A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 11 | VAL A 128GLY A 44PHE A 45SER A 236ASP A 126 | 1.79A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 7bv1 | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | VAL A 424ALA A 423TYR A 420GLY A 432ASP C 5 | 1.59A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 165LEU A 127ILE A 145ALA A 176THR A 248 | 1.44A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 11 | ASP A 717VAL A 776ALA A 771TYR A 770GLY A 774 | 1.59A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 480LEU A 575ILE A 579ALA A 634THR A 686 | 1.61A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | ILE B 119ALA B 150ALA B 125GLY A 385THR B 124 | 1.55A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 11 | TYR A 887ASP A 418VAL A 848GLY A 841ASP A 851 | 1.69A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ILE A 450ALA A 558GLY A 559ALA A 449THR A 556 | 1.64A | NoneNone U T 10 ( 3.5A)NoneNone | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 165LEU A 127ILE A 145ALA A 176THR A 248 | 1.47A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 270ALA B 150ALA B 125GLY A 385THR B 123 | 1.57A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 638ALA A 685THR A 687GLY A 679ALA A 634 | 1.66A | None A T 11 ( 4.7A)F86 P 102 (-3.6A)NoneNone | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | ILE B 119ALA B 150ALA B 125GLY A 385THR B 124 | 1.53A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 9 | ASP A 135ASN A 138ILE A 779SER A 784THR A 801 | 1.61A | 19.42 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 9 | ILE B 119SER A 397SER A 325GLY A 327THR B 123 | 1.72A | 17.43 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 7bv2 | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | VAL A 424ALA A 423TYR A 420GLY A 432ASP C 5 | 1.60A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 480LEU A 575ILE A 579ALA A 634THR A 686 | 1.61A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 11 | VAL A 128GLY A 44PHE A 45SER A 236ASP A 126 | 1.76A | None |